Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Nurofen maker Reckitt Benckiser fined in Australia
Nurofen maker Reckitt Benckiser fined in Australia
The manufacturer of Nurofen, Reckitt Benckiser, has been fined A$1.
Ackman, Valeant pledge reforms after spiking drug prices
Ackman, Valeant pledge reforms after spiking drug prices
Activist investor William Ackman promised U.
Singapore’s manufacturing sector performs better than expected on strong pharmaceuticals
Singapore’s manufacturing sector performs better than expected on strong pharmaceuticals
Singapore’s headline industrial production data indicated that the overall manufacturing fell only 0.
14 people fatally overdose on 'painkiller' in California
14 people fatally overdose on 'painkiller' in California
SAN FRANCISCO — Fourteen people in the Sacramento, California, area have fatally overdosed on a pill disguised as a popular painkiller, and now the drug has turned up in the San Francisco Bay Area.
Lilly's Taltz cleared in the EU for plaque psoriasis
Lilly's Taltz cleared in the EU for plaque psoriasis
The European Commission has approved Eli Lilly’s biologic Taltz as a new treatment for moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy.
Intrexon’s Subsidiary Exemplar Genetics Receives FDA Approval for ExeGen as Research Model for Commercial Use (NYSE:XON)
Intrexon’s Subsidiary Exemplar Genetics Receives FDA Approval for ExeGen as Research Model for Commercial Use (NYSE:XON)
Intrexon (NYSE.
AZ hands off gout drug Zurampic to Ironwood for $100M-plus
AZ hands off gout drug Zurampic to Ironwood for $100M-plus
LesinuradDid Ironwood Pharmaceuticals just pick up a promising product, or did AstraZeneca just unload a problematic one? You be the judge.
DuPont expects SEC review of Dow deal to end by June 30
DuPont expects SEC review of Dow deal to end by June 30
DuPont said on Tuesday it expected the U.
Alexion mulls producing pipeline drugs in Ireland
Alexion mulls producing pipeline drugs in Ireland
A senior executive with Alexion ($ALXN), the maker of orphan drug Soliris, said the company is taking a hard look at locating facilities to produce its new pipeline of drugs in Ireland.
Chinese Scientists Modify Gene To Make Humans Immune To HIV Infection
Chinese Scientists Modify Gene To Make Humans Immune To HIV Infection
BEIJING.
TECFIDERA® data highlights benefit of early treatment in relapsing-remitting multiple sclerosis
TECFIDERA® data highlights benefit of early treatment in relapsing-remitting multiple sclerosis
Biogen present new TECFIDERA (dimethyl fumarate) research at the 68thannual meeting of the American Academy of Neurology (AAN) in Vancouver, Canada.
Study identifies compound that reverses symptoms of Alzheimer's, Parkinson's
Study identifies compound that reverses symptoms of Alzheimer's, Parkinson's
Alzheimer's and Parkinson's disease are the two most common neurodegenerative disorders worldwide and cause untold suffering to millions of patients and their families.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand